Stanford's Anshul Kundaje calls BioReason's variant effect prediction evals seriously flawed

anshulkundaje · x · 2026-10-23

Stanford professor Anshul Kundaje criticized current variant effect prediction evals as not serious: BioReason's evaluations are "extremely flawed," with unclear handling of train/test leakage, and most other evals are pointless. He argues model builders should instead benchmark against established resources like AlphaMissense, PromoterAI, AlphaGenome, SpliceAI/2 and TraitGym.

Original post →

More from Research

Research channel →